Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Fulcrum Therapeutics, Inc. (FULC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/09/2023 |
3
| Musso Alan A (CFO) has filed a Form 3 on Fulcrum Therapeutics, Inc. |
| 07/03/2023 |
3
| Sapir Alex (See Remarks) has filed a Form 3 on Fulcrum Therapeutics, Inc. |
| 11/09/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/26/2022 |
3
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 3 on Fulcrum Therapeutics, Inc. |
| 08/11/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/14/2022 |
3
| Tourangeau Greg (Controller) has filed a Form 3 on Fulcrum Therapeutics, Inc. |
| 01/10/2022 |
3
| Rajavelu Esther (CFO) has filed a Form 3 on Fulcrum Therapeutics, Inc. |
| 12/09/2021 |
3
| Banks Sonja (Director) has filed a Form 3 on Fulcrum Therapeutics, Inc. |
| 05/12/2021 |
3
| Morabito Christopher (Chief Medical Officer) has filed a Form 3 on Fulcrum Therapeutics, Inc. |
| 04/02/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/10/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/07/2020 |
3
| Oltmans Curtis Gale (SVP, General Counsel) has filed a Form 3 on Fulcrum Therapeutics, Inc. |
| 01/06/2020 |
3
| Dorton Katina (Director) has filed a Form 3 on Fulcrum Therapeutics, Inc. |
| 07/17/2019 |
3
| 6 Dimensions Capital, L.P. (10% Owner) has filed a Form 3 on Fulcrum Therapeutics, Inc. |
| 07/17/2019 |
3
| Section 32 Fund 2, LP (10% Owner) has filed a Form 3 on Fulcrum Therapeutics, Inc. |
| 07/17/2019 |
3
| Stuart Bryan (COO) has filed a Form 3 on Fulcrum Therapeutics, Inc. |
| 07/17/2019 |
3
| LEVIN MARK J (10% Owner) has filed a Form 3 on Fulcrum Therapeutics, Inc. |
| 07/17/2019 |
3
| Casdin Capital, LLC (10% Owner) has filed a Form 3 on Fulcrum Therapeutics, Inc. |
| 07/17/2019 |
3
| Cadavid Diego (See Remarks) has filed a Form 3 on Fulcrum Therapeutics, Inc. |
| 07/17/2019 |
3
| Haviland Kate (Director) has filed a Form 3 on Fulcrum Therapeutics, Inc. |
| 07/17/2019 |
3
| Ezekowitz Alan (Director) has filed a Form 3 on Fulcrum Therapeutics, Inc. |
| 07/17/2019 |
3
| Thomson Peter G. (See Remarks) has filed a Form 3 on Fulcrum Therapeutics, Inc. |
| 07/17/2019 |
3
| Gould Robert J (See Remarks) has filed a Form 3 on Fulcrum Therapeutics, Inc. |
| 07/17/2019 |
3
| Wallace Owen B. (Chief Scientific Officer) has filed a Form 3 on Fulcrum Therapeutics, Inc. |
| 07/17/2019 |
3
| GLAXOSMITHKLINE PLC (10% Owner) has filed a Form 3 on Fulcrum Therapeutics, Inc. |
| 07/17/2019 |
3
| Collins James J. (Director) has filed a Form 3 on Fulcrum Therapeutics, Inc. |
| 07/17/2019 |
3
| GERAGHTY JAMES A (Director) has filed a Form 3 on Fulcrum Therapeutics, Inc. |
| 07/17/2019 |
3
| Sanofi (10% Owner) has filed a Form 3 on Fulcrum Therapeutics, Inc. |
| 07/17/2019 |
3
| Third Rock Ventures IV, L.P. (10% Owner) has filed a Form 3 on Fulcrum Therapeutics, Inc. |
| 07/17/2019 |
3
| Third Rock Ventures III, L.P. (10% Owner) has filed a Form 3 on Fulcrum Therapeutics, Inc. |
|
|